- Home
- FHTX vs EVG Comparison
FHTX vs EVG Comparison
Compare FHTX & EVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FHTX | EVG |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 173.4M | 142.6M |
| IPO Year | 2020 | 2004 |
Fundamental Metrics
Financial Performance| Metric | FHTX | EVG |
|---|---|---|
| Price | $1.92 | $10.03 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 38.6K |
| Earning Date | 11-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,909,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $15.98 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 36.75 | N/A |
| 52 Week Low | $1.79 | $9.78 |
| 52 Week High | $7.61 | $11.34 |
Technical Indicators
Market Signals| Indicator | FHTX | EVG |
|---|---|---|
| Relative Strength Index (RSI) | 15.14 | 46.43 |
| Support Level | N/A | $9.78 |
| Resistance Level | $5.35 | $11.00 |
| Average True Range (ATR) | 0.30 | 0.19 |
| MACD | -0.16 | 0.02 |
| Stochastic Oscillator | 5.53 | 68.22 |
Price Performance
Historical ComparisonAbout FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
About EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest
Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.